Implantable cardioverter-defibrillator (ICD)

EBM Guidelines
Aug 12, 2022 • Latest change Nov 16, 2022
Pekka Raatikainen and Jarkko Karvonen

Table of contents

Extract

  • The indications for implantable cardioverter-defibrillator (ICD) therapy should be known.
  • The principles of ICD function and the impact the treatment has on the patient’s everyday life should be understood.
  • Signs and symptoms suggestive of device malfunction should be recognized. If indicated, an extra visit should be arranged at a pacemaker clinic.

Read full article of Implantable cardioverter-defibrillator (ICD)

Search terms

Asystole, Asystoles, Brugada Syndrome, Cardiac Arrest, Cardiac Pacing, Artificial, Cardiac pacemaker, Cardiology, Cardiomyopathy, Cardiopulmonary Arrest, Cardioversion, Defibrillation, Electric, Defibrillators, Defibrillators, Implantable, Electric Countershock, Electroversion, Cardiac, Electroversions, Cardiac, Heart Arrest, ICD, Implantable Cardioverter-Defibrillators, Implantable cardioverter-defibrillator, Internal medicine, Long QT Syndrome, Pace-maker, Pacemaker, Pacemaker, Artificial, T82.1, Therapy, Electroversion, VF, VT, Ventricular Fibrillation, Ventricular tachycardia, Z45.0, Z95.0